Texas (November 29, 2013) Wax Ink has issued a Positive Investment Interest opinion for Rubicon Technology, Inc. (Nasdaq: RBCN) based on a recent baseline equity review that placed fair value between $19-$22.
Positive (buy) investment interest means that the current key performance indicators (KPIs) favor investment consideration at this time.
The recent close of $10.01 is approximately 13% below the fair value buy target for the stock and approximately 58% below the fair value close target for the stock. The recent close is also 5% above analysts’ twelve-month $9.50 median price target for the stock.
The recent close represents a 56% increase in the one-year price of the stock, while year-over-year sales decreased 50%, year-over-year earnings decreased 87%, year-over-year debt remained at $0.0, and year-over-year free cash flow decreased 23%.
The stock currently has a trailing twelve-month PE Ratio of 38, and a PEG Ratio of 2.5 basis estimated forward earnings growth of 15%.
In the past 52 weeks, share prices have moved between a high of $13.78 and a low of $4.83, placing equilibrium at $9.44.
With the recent close, the stock is trading 38% below the 52 week high, 52% above the 52 week low, and 6% above equilibrium.
The three-month average daily trading volume for this stock is approximately 507,000 shares and the average daily volume is approximately 739,000 shares. There are approximately 7.7 million short interest shares which places the days to cover at 10.
Rubicon Technology, Inc. is an electronic materials provider that develops, manufactures and sells monocrystalline sapphire and other crystalline products for light-emitting diodes, radio frequency integrated circuits, blue laser diodes, optoelectronics and other optical applications.
The company’s listed competitors include Cree, Inc., Nichia Corporation,and Soitec S.A..
Financial information contained herein, is based on the company’s most recent annual SEC filing for year ending December 31, 2012 and all prices are per share unless otherwise noted.
Wax Ink currently has no investment position in any company mentioned in this alert.
For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D.
Copyright © 2013 Wax Ink
Wax Ink is a baseline equity research company not licensed or registered with any government agency